Fibrinogen-to-Albumin Ratio as a Predictor of Acute Respiratory Distress Syndrome in Traumatic Brain Injury
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTanta University
About this trial
this study aims to assess the ability of fibrinogen-to-albumin ratio to predict the development of Acute respiratory distress syndrome in traumatic brain injury patients.
Eligibility criteria
Qualifiers
Patients ≥ 18 years admitted to the ICU with traumatic Brain Injury
Admission to the ICU within 24 hours of injury.
Patients will be expected to remain under hospital care for follow-up
Availability of fibrinogen and albumin measurements within the first 24 hours of ICU admission.
Disqualifiers
Preexisting advanced chronic liver disease, nephrotic syndrome, or protein-losing enteropathy.
Pre-existing ARDS on admission.
Recipient of albumin, fibrinogen concentrate, or cryoprecipitate before admission sampling.
Use of anticoagulant or fibrinolytic therapy before admission.
Trial design
Treatments tested in this trial
- Fibrinogen-to-albumin ratio
Treatment groups
350 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov